Adam S. Grossman
Net Worth

Last updated:

What is Adam S. Grossman net worth?

The estimated net worth of Mr. Adam S. Grossman is at least $64,714,154 as of 22 Nov 2024. He owns shares worth $34,767,842 as insider, has earned $16,386,312 from insider trading and has received compensation worth at least $13,560,000 in ADMA Biologics, Inc..

What is the salary of Adam S. Grossman?

Mr. Adam S. Grossman salary is $1,130,000 per year as Co-Founder, Pres, Chief Executive Officer & Director in ADMA Biologics, Inc..

How old is Adam S. Grossman?

Mr. Adam S. Grossman is 48 years old, born in 1977.

What stocks does Adam S. Grossman currently own?

As insider, Mr. Adam S. Grossman owns shares in one company:

Company Title Shares Price per share Total value
ADMA Biologics, Inc. (ADMA) Co-Founder, Pres, Chief Executive Officer & Director 1,989,007 $17.48 $34,767,842

What does ADMA Biologics, Inc. do?

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA logo
ADMA
ADMA Biologics, Inc.
$17.48

Adam S. Grossman insider trading

ADMA Biologics, Inc.

Mr. Adam S. Grossman has made 7 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 48,967 units of ADMA stock worth $1,033,204 on 22 Nov 2024.

The largest trade he's ever made was exercising 1,333,224 units of ADMA stock on 15 Aug 2023. As of 22 Nov 2024 he still owns at least 1,989,007 units of ADMA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 48,967 $21.1 $1,033,204
Option
Common Stock 47,396 $2.92 $138,159
Option
Common Stock 341,960 $3.35 $1,145,566
Sale
Common Stock 389,356 $17.29 $6,732,744
Option
Common Stock 341,960 $3.35 $1,145,566
Option
Common Stock 47,396 $2.92 $138,159
Option
Common Stock 64,405 $3.35 $215,757
Option
Common Stock 16,984 $5.96 $101,225
Option
Common Stock 40,500 $9.37 $379,485
Option
Common Stock 64,405 $3.35 $215,757
Option
Common Stock 60,000 $10.8 $648,000
Sale
Common Stock 236,889 $17.69 $4,191,040
Option
Common Stock 172,484 $7.78 $1,342,443
Option
Common Stock 55,000 $5 $275,000
Sale
Common Stock 100,000 $10.72 $1,072,000
Sale
Common Stock 250,000 $4.15 $1,038,250
Sale
Common Stock 3 $4.39 $13
Option
Common Stock 1,333,224 $3.53 $4,706,281
Sale
Common Stock 510,469 $4.54 $2,319,061
Option
Common Stock 277,604 $2.92 $809,216
Option
Common Stock 277,131 $2.35 $651,258
Option
Common Stock 212,500 $1.67 $354,875
Option
Common Stock 212,500 $1.67 $354,875
Option
Common Stock 277,131 $2.35 $651,258
Option
Common Stock 277,604 $2.92 $809,216
Option
Common Stock 400,000 $3.22 $1,288,000
Option
Common Stock 350,000 $3.71 $1,298,500
Option
Common Stock 583,224 $3.66 $2,134,600
Purchase
Common Stock 14,983 $2.86 $42,851
Purchase
Common Stock 14,982 $2.86 $42,849
Purchase
Common Stock 100,000 $1 $100,000
Purchase
Common Stock 250,000 $1 $250,000
Purchase
Common Stock 4,000 $2.24 $8,960
Purchase
Common Stock 1,000 $2.97 $2,970
Purchase
Common Stock 5,000 $3.06 $15,285
Purchase
Common Stock 85,714 $3.5 $299,999
Purchase
Common Stock 30,000 $4 $120,000
Purchase
Common Stock 73,222 $4.78 $350,001
Purchase
Common Stock 485,000 $2.15 $1,042,750
Option
Common Stock 42,021 $2.68 $112,616
Option
Employee Stock Option (right to buy) 42,021 $2.68 $112,616
Purchase
Common Stock, $0.0001 par value per share 200,000 $6.5 $1,300,000
Purchase
Common Stock, $0.0001 par value per share 6,400 $8.47 $54,227
Purchase
Common Stock, $0.0001 par value per share 300 $8.99 $2,697
Purchase
Common Stock, $0.0001 par value per share 200 $9.01 $1,803
Purchase
Common Stock, $0.0001 par value per share 2,250 $9.15 $20,590
Purchase
Common Stock, $0.0001 par value per share 1,800 $9.17 $16,513
Purchase
Common Stock, $0.0001 par value per share 1,800 $9.18 $16,529
Purchase
Common Stock, $0.0001 par value per share 2,861 $9.19 $26,290
Purchase
Common Stock, $0.0001 par value per share 1,000 $9.13 $9,134
Purchase
Common Stock, $0.0001 par value per share 2,000 $8.5 $16,996
Purchase
Common Stock, $0.0001 par value per share 5,500 $7.98 $43,879
Purchase
Common Stock, $0.0001 par value per share 9,100 $8 $72,764
Purchase
Common Stock, $0.0001 par value per share 300 $10 $3,000
Purchase
Common Stock, $0.0001 par value per share 4,000 $9.58 $38,300
Purchase
Common Stock, $0.0001 par value per share 1,000 $9.5 $9,500
Purchase
Common Stock, $0.0001 par value per share 600 $9.5 $5,700
Purchase
Common Stock, $0.0001 par value per share 1,100 $9.74 $10,714
Purchase
Common Stock, $0.0001 par value per share 1,000 $9.81 $9,810
Purchase
Common Stock, $0.0001 par value per share 1,875 $9.59 $17,981
Purchase
Common Stock, $0.0001 par value per share 425 $9.5 $4,038
Purchase
Common Stock, $0.0001 par value per share 200 $9 $1,800
Purchase
Common Stock, $0.0001 par value per share 500 $8.24 $4,120
Purchase
Common Stock, $0.0001 par value per share 2,000 $8.08 $16,160
Purchase
Common Stock, $0.0001 par value per share 2,226 $8.21 $18,275
Purchase
Common Stock, $0.0001 par value per share 874 $8.07 $7,053
Purchase
Common Stock, $0.0001 par value per share 9,900 $7.45 $73,706
Purchase
Common Stock, $0.0001 par value per share 3,500 $7.45 $26,075
Purchase
Common Stock, $0.0001 par value per share 23,529 $8.5 $199,997

ADMA Biologics key executives

ADMA Biologics, Inc. executives and other stock owners filed with the SEC: